2018 Speakers

Charles Hamilton is a director and member of the Piper Jaffray healthcare investment banking team, focusing on medical technology companies. Hamilton has 14 years of healthcare investment banking and capital markets experience. He has advised public and private clients through a broad range of investment banking services, including sell-side and buy-side mergers and acquisitions as…

Badrul A. Chowdhury is Senior Vice President and Head Respiratory, Inflammation and Autoimmunity at MedImmune. He was previously the Director, Division of Pulmonary, Allergy, and Rheumatology Products, Center for Drug Evaluation and Research at the US FDA. While at the FDA, Dr. Chowdhury provided scientific and regulatory oversight of medicines in highly prevalent diseases, such…

Anthony Flores is a Managing Director and the Head of Southwest Life Sciences & Healthcare within Silicon Valley Bank’s National Life Science Division. He joined Silicon Valley Bank (SVB) in 2012 and oversees a client portfolio comprised of the over 300 of the region’s top life science & healthcare companies. Anthony and his team work…

Jim serves as Executive Vice President and Chief Product and Innovation Officer for newly formed Vyaire Medical in Mettawa, IL. In his role, Jim is responsible for marketing and research and development and managing the full product innovation cycle. Jim has spent over twenty years in the medical device industry, serving most recently as the…

Benjamin Kramer, MD is the Vice President, Medical Affairs for Immunology and Ophthalmology at Genentech. He has worked for nearly 20 years in the pharmaceutical industry, with significant leadership experience in both global clinical development and global medical affairs in respiratory, urology and immunology. Ben came to Genentech in 2012 from Novartis, where he acted…

Jimmy Rosen is Managing Partner of Three Lakes Partners, a Venture Philanthropy on a mission to end Idiopathic Pulmonary Fibrosis (IPF). Three Lakes Partners is attacking IPF from all sides: diagnosis, treatment, patient quality of life, research, and funding all by engaging the most innovative, aggressive and experienced partners in their fight against IPF. Jimmy…

Linda Armstrong has led the Global Respiratory Development Unit at Novartis Pharmaceutical Co. since November 1, 2016. Prior to this role, she was the CMO and Head of Medical Affairs for the Novartis Cell & Gene Therapies Unit. Linda has had jobs of increasing responsibility in Clinical Development, Patient Safety and Medical Affairs, supporting numerous…

Chau Quang Khuong is Partner in the Private Equity group at OrbiMed Advisors, a global healthcare-dedicated investment firm with approximately $15 billion in assets under management. During his investment career, Mr. Khuong has been actively involved in innovative drug development and medical device enterprises across all stages and therapeutic areas including respiratory, oncology, infectious diseases,…

Onaiza Cadoret Manier is an international commercialization and operations executive with 25 years driving growth for Fortune 500 and start-up companies—Genentech, Pfizer, and Amylin Pharmaceuticals. She is recognized for strategic and inspirational leadership, launching new products, and reviving landmark brands across multiple therapeutic areas. Onaiza has been at Genentech since 2011 leading and building the…

A follower and fan of medtech for nearly two decades, Tom Salemi is the former Bureau Chief, Venture Capital, at Elsevier Business Intelligence, where he oversaw coverage of venture investments in medtech. Prior to working at Elsevier, he served as Senior Staff Writer at Windhover Information and news editor at Dow Jones where he edited…